Drug name - Edurant
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8080551 | JANSSEN PRODS | HIV inhibiting pyrimidines derivatives |
Apr, 2023
(6 months from now) | |
| US7125879 | JANSSEN PRODS | HIV inhibiting pyrimidines derivatives |
Apr, 2025
(2 years from now) | |
| CN101056673A | JANSSEN PRODS | 4-[[4-[[4-(2-Cyanovinyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidyl]Amino] Benzonitrile Hydrochloride |
Jun, 2015
(7 years ago) | |
| CN101816658A | JANSSEN PRODS | Pyramine Derivatives For Inhibiting Hiv |
Aug, 2022
(a month ago) | |
| CN101816658B | JANSSEN PRODS | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| CN1541215A | JANSSEN PRODS | Hiv Inhibiting Pyrimidine Derivatives |
Aug, 2022
(a month ago) | |
| CN100509801C | JANSSEN PRODS | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| CN101060844A | JANSSEN PRODS | Composition Of Rt Inhibitor And Nnrti Containing Pyrimidine |
Sep, 2024
(1 year, 10 months from now) | |
| CN101068597A | JANSSEN PRODS | Fumaric Acid Salt Of 4-((4-((4-(2-Cyanovinyl)-2, 6-) Dimethylphenyl Amido)-2- Pyrimidyl) Amido) Benzonitrile |
Sep, 2024
(1 year, 10 months from now) | |
| CN101068597B | JANSSEN PRODS | 4 - ((4 - ((4 - (2) -2, 6 -) Dimethylphenyl Amido) -2 - Pyrimidyl) Amido) Benzonitrile |
Sep, 2024
(1 year, 10 months from now) | |
| CN101060844B | JANSSEN PRODS | Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors |
Sep, 2024
(1 year, 10 months from now) | |
| IN200400265P1 | JANSSEN PRODS | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| IN222987B | JANSSEN PRODS | A Pyrimidine Compound Of Formula (I) |
Aug, 2022
(a month ago) | |
| EP1663240A1 | JANSSEN PRODS | Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors |
Jul, 2020
(2 years ago) | |
| EP1663240B1 | JANSSEN PRODS | Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors |
Jul, 2020
(2 years ago) | |
| EP1632232A1 | JANSSEN PRODS | Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile |
Feb, 2022
(7 months ago) | |
| EP1632232B1 | JANSSEN PRODS | Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile |
Feb, 2022
(7 months ago) | |
| EP3808743B1 | JANSSEN PRODS | Hiv Replication Inhibiting Pyrimidines |
Aug, 2022
(a month ago) | |
| EP2298761B1 | JANSSEN PRODS | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| EP3808743A1 | JANSSEN PRODS | Hiv Replication Inhibiting Pyrimidines |
Aug, 2022
(a month ago) | |
| EP2298761A1 | JANSSEN PRODS | Hiv Inhibiting Pyrimidines Derivatives |
Aug, 2022
(a month ago) | |
| EP1789139A1 | JANSSEN PRODS | Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile |
Sep, 2025
(2 years from now) | |
| EP1789139B1 | JANSSEN PRODS | Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile |
Sep, 2025
(2 years from now) | |
| EP1419152B1 | JANSSEN PRODS | Hiv Inhibiting Pyrimidines Derivatives |
Nov, 2026
(4 years from now) | |
| EP1419152A1 | JANSSEN PRODS | Hiv Inhibiting Pyrimidines Derivatives |
Nov, 2026
(4 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7638522 | JANSSEN PRODS | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile |
Apr, 2023
(6 months from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 25MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.